Work

The safety and early efficacy of high-dose ipilimumab (IPI) and the combination nivolumab plus ipilimumab (NIVO + IPI) in patients (pts) with uveal melanoma (UM).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.9554

Authors: Sapna Pradyuman Patel, Isabella Claudia Glitza, Adi Diab, Rodabe Navroze Amaria, Michael A. Davies, Patrick Hwu, Hussein Abdul-Hassan Tawbi, Wen-Jen Hwu

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889815180

Cites:

Cited by: 8

Related to: 10